_256_384.jpg){kind=logo}
News | September 16, 2022
Everstone acquires controlling stake in Softgel Healthcare
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of US $202 mn in the US
Celgene agreed to provide Dr. Reddy's with a license to sell volume-limited amounts of generic lenalidomide capsules in the U.S.
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
This launch builds upon Hikma’s leading position as one of the largest US providers of nasally administered medicines used for treating seasonal allergies and advances its objective of growing its specialty business in the US
Pending authorization, Moderna ready to ship bivalent booster mRNA-1273.222 in September
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Desvenlafaxine Extended-Release Tablets, 25 mg is a generic equivalent of Pristiq Extended-Release Tablets, 25 mg of PF PRISM C.V.
Subscribe To Our Newsletter & Stay Updated
